{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:45:00Z","timestamp":1760705100878},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1093\/humrep\/17.7.1676-a","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T22:39:17Z","timestamp":1027895957000},"page":"1676-1680","source":"Crossref","is-referenced-by-count":14,"title":["Bye-bye urinary gonadotrophins?"],"prefix":"10.1093","volume":"17","author":[{"given":"Adam","family":"Balen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,7]]},"reference":[{"key":"key\n\t\t\t\t20170410040529_BALEN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Balen, A.H., Hayden, C. and Rutherford, A.J. (1999) What are the value of the recombinant gonadotrophins? Hum. Reprod., 14, 1411\u20131417.","DOI":"10.1093\/humrep\/14.6.1411"},{"key":"key\n\t\t\t\t20170410040529_BARLOW-2001","doi-asserted-by":"crossref","unstructured":"Barlow, D. (2001) Cost effectiveness modelling. Hum. Reprod., 16, 2479\u20132480.","DOI":"10.1093\/humrep\/16.12.2479"},{"key":"key\n\t\t\t\t20170410040529_BRITISH-PHARMACOPOEIA-2001","unstructured":"British Pharmacopoeia (2001) Menotrophin 1067."},{"key":"key\n\t\t\t\t20170410040529_BRUCE-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Bruce, M.E., Will, R.G., Ironside, J.W., McConnell, I., Drummond, D., Suttie, A., McArdle, L., Chree, A., Hope, J., Birkett, C., Cousens, S., Fraser, H. and Bostock, C.J. (1997) Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent. Nature, 389, 498\u2013501.","DOI":"10.1038\/39057"},{"key":"key\n\t\t\t\t20170410040529_COMMITTEE-ON-SAFETY-OF-MEDICINES-1988","unstructured":"Committee on Safety of Medicines, Scientific Committee on Medicinal Products and Medical Devices (1988) Opinion on the risk quantification for CJD transmission via substances of human origin."},{"key":"key\n\t\t\t\t20170410040529_DAYA-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Daya, S., Ledger, W., Auray, J.P., Duru, G., Silverberg, K., Wikland, M., Bouzayen, R., Howles, C.M. and Beresniak, A. (2001) Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK. Hum. Reprod., 16, 2563\u20132569.","DOI":"10.1093\/humrep\/16.12.2563"},{"key":"key\n\t\t\t\t20170410040529_DEPARTMENT-HEALTH-2001A","unstructured":"Department of Health (2001a) First Annual Report 2000\u20132001 to the Joint Working Group on Transmissible Spongiform Encephalopathies of the Spongiform Encephalopathy Advisory Committee and the Advisory Committee on Dangerous Pathogens. (Department of Health Government Website, UK)."},{"key":"key\n\t\t\t\t20170410040529_DEPARTMENT-HEALTH-2001B","unstructured":"Department of Health (2001b) Monthly CJD Statistics published by the Department of Health at www.doh.gov.uk\/cjd\/cjd_stat.htm."},{"key":"key\n\t\t\t\t20170410040529_DONINI-AND-MONTEZEMOLO-1949","unstructured":"Donini, P. and Montezemolo, R. (1949) Rassegna di Clinica, Terapia e Scienze Affini. A publication of the Biologic Laboratories of the Instituto Serono., 48, 3\u201328."},{"key":"key\n\t\t\t\t20170410040529_FISCHER-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Fischer, M.B., Roeckl, C., Parizek, P., Schwarz, H.P. and Aguzzi, A. (2000) Binding of disease-associated prion protein to plasminogen. Nature, 408, 479\u2013483.","DOI":"10.1038\/35044100"},{"key":"key\n\t\t\t\t20170410040529_FOSTER-2000","doi-asserted-by":"crossref","unstructured":"Foster, P.R. (2000) Prions and blood products (Review). Ann. Med., 32, 501\u2013513.","DOI":"10.3109\/07853890009002026"},{"key":"key\n\t\t\t\t20170410040529_GABIZON-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Gabizon, R., Telling, G., Meiner, Z., Halimi, M., Kahana, I. and Prusiner, S.B. (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nature Med., 2, 59\u201364.","DOI":"10.1038\/nm0196-59"},{"key":"key\n\t\t\t\t20170410040529_HADLOW-ETAL-1980","doi-asserted-by":"crossref","unstructured":"Hadlow, W.J., Kennedy R.C., Race, R.E. and Eklund, C.M. (1980) Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet. Pathol., 17, 187\u2013199.","DOI":"10.1177\/030098588001700207"},{"key":"key\n\t\t\t\t20170410040529_HADLOW-ETAL-1982","doi-asserted-by":"crossref","unstructured":"Hadlow, W.J., Kennedy R.C. and Race, R.E. (1982) Natural infection of Suffolk sheep with scrapie virus. J. Infect. Diseases, 146, 657\u2013664.","DOI":"10.1093\/infdis\/146.5.657"},{"key":"key\n\t\t\t\t20170410040529_HAYDEN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Hayden, C.J., Balen, A.H. and Rutherford, A.J. (1999) Recombinant gonadotrophins. Br. J. Obs. Gynaecol., 106, 188\u2013196.","DOI":"10.1111\/j.1471-0528.1999.tb08230.x"},{"key":"key\n\t\t\t\t20170410040529_LUNENFELD-ETAL-1962","unstructured":"Lunenfeld, B., Sulmovici, S., Rabau, E. and Eshkol, A. (1962) L'induction de l'ovulation dans les amenorrhees hypophysaires par an traitment combine de gonadotrophines urinaires menopausiques et de gonadotrophines chorioniques. C. R. Soc. Francaise de Gynecol., 5, 1\u20136."},{"key":"key\n\t\t\t\t20170410040529_MATORRAS-AND-RODRIGUEZ-ESCUDERO-2002","doi-asserted-by":"crossref","unstructured":"Matorras, R. and Rodr\u00edguez-Escudero, F.J. (2002) Bye-bye urinary gonadotrophins? The use of urinary gonadotrophins should be discouraged. Hum. Reprod., 17, xxxx.","DOI":"10.1093\/humrep\/17.7.1675"},{"key":"key\n\t\t\t\t20170410040529_NATIONAL-SURVEILLANCE-UNIT-2000","unstructured":"National CJD Surveillance Unit (2000) Ninth Annual Report 2000. Creutzfeldt-Jakob Disease Surveillance in the UK. The National CJD Surveillance Unit. www.cjd.ed.ac.uk"},{"key":"key\n\t\t\t\t20170410040529_RECOMBINANT-HUMAN-FSH-PRODUCT-DEVELOPMENT-GROUP-1998","doi-asserted-by":"crossref","unstructured":"Recombinant Human FSH Product Development Group (1998) Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility. Hum. Reprod. Update, 862\u2013881.","DOI":"10.1093\/humupd\/4.6.862"},{"key":"key\n\t\t\t\t20170410040529_SHAKED-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Shaked, G.M., Shaked, Y., Kariva, Z., Halimi, M., Avraham, I. and Gabizon, R. (2001) A protease resistant PrP isoform is present in urine of animals and humans affected with Prion diseases. J. Biol. Chem., 276, 31479\u201331482.","DOI":"10.1074\/jbc.C100278200"},{"key":"key\n\t\t\t\t20170410040529_SYKES-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Sykes, D., Out, H.J., Palmer, S.J. and van Loon, J. (2001) The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin regimens. Hum. Reprod., 16, 2563\u20132569.","DOI":"10.1093\/humrep\/16.12.2557"},{"key":"key\n\t\t\t\t20170410040529_WILL-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Will, R.G., Ironside, J.W., Zeidler, M., Cousens, S.N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A. and Smith, P.G. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921\u2013925.","DOI":"10.1016\/S0140-6736(96)91412-9"},{"key":"key\n\t\t\t\t20170410040529_WORLD-HEALTH-ORGANIZATION-1997","unstructured":"World Health Organization (1997) Report of a WHO Consultation on Medicinal and other Products in Relation to Human and Animal Transmissible Spongiform Encephalopathies."}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/17\/7\/1676\/11537184\/0171676a.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T21:13:24Z","timestamp":1583442804000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/17.7.1676-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2002,7]]},"published-print":{"date-parts":[[2002,7]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/17.7.1676-a","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}